The Board of Directors The Board of Directors consists of 9 directors of which Name Position 1. Mr.Lopchai Kaenratana Chairman 2. Dr. Prompan Prommas, M.D. Director / Nomination Director 3. Mrs. Patama Prommas Director / Remuneration Director 4. Mrs.Prompan Siripat Director / Nomination Chairman 5. Dr. Saravut Sontikaew,M.D. Director 6. Dr. Kamales Santivejkul,Ph.D. Independence Director / Remuneration Director 7. Dr. Prawit Ninsuvannakul,Ph.D. Independence Director / Audit Committee Chairman 8. Dr. Charoon Chairoj, M.D. Independence Director / Audit Committee Director / Remuneration Chairman 9. Dr. Viroonporn Prompongsa, M.D. Independence Director / Audit Committee Director / Nomination Director Miss Suree Sangkornpanich Secretary Company Director Authorized to sign on Behalf of the Company Mr. Lopchai Kaenrattana or Dr. Prompan Prommas, M.D. or Mrs.Patama Prommas , two directors sign jointly and affix the companyIs seal. The Board of Directors< Scope of Authorities 1. Management must observe laws, rules, and objectives set out by the company. They also are responsible for the protection of the shareholdersIbenefits as well as obliged to the decision made at the shareholdersI meeting. 2. Responsible to setting up policy and vision for the company. They must monitor the performance of the companyIs management to ensure that it is being done in accordance to the policy set out by the Board of Directors. The companyIs management must be done in an effective and efficient manner. 3. Set out effective internal audit and internal control system for the company. 4. Monitor closely the operation of the company to ensure the companyIs compliance with laws and rules prescribed by the company. This will lead to an efficient operation for the company as a whole. 5. Call for the shareholdersI meeting. The shareholdersI meeting shall oblige by the standard procedures prescribed for SETIs registered company to ensure transparency and fairness. 6. Responsible for reporting financial and general information of the company to the shareholders and general investors in a completed and transparent manner.
32